20.500.12556/DiRROS-13875
Selective response to omalizumab in a patient with concomitant ncMCAS and POTS : what does it teach us about the underlying disease?
mastocytosis
postural orthostatic tachycardia syndrome
omalizumab
nonclonal mast cell activation syndrome
mastocitoza
posturalna ortostatska tahikardija
omalizumab
neklonski sindrom aktivacije mastocitov
true
false
true
ESMON Publicidad
Angleški jezik
Ni določen
© 2018 Esmon Publicidad
Neznano
2021-04-08 14:56:14
2021-04-08 14:56:14
2022-08-19 03:37:20
0000-00-00 00:00:00
2018
0
Španija
0
Nasl. z nasl. zaslona;
Opis vira z dne 7. 4. 2021;
str. 261-263
iss. 4
Vol. 28
2018
0000-00-00
Zaloznikova
Objavljeno
NiDoloceno
0000-00-00
0000-00-00
0000-00-00
616-097
1698-0808
10.18176/jiaci.0251
58573827
http://www.jiaci.org/revistas/vol28issue4_9.pdf
1
https://dirros.openscience.si/Dokument.php?lang=slv&id=16987
Univerzitetna klinika za pljučne bolezni in alergijo Golnik
0
0
0